Herbas VPB

Print
EN | LT
LT - FLUTICASONE FUROATE IN THE TREATMENT OF COPD
EN - FLUTICASONE FUROATE IN THE TREATMENT OF COPD

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/138 (2006.01)
A61K 31/138 (2013.01)
A61K 31/439 (2006.01)
A61K 31/439 (2013.01)
A61K 31/58 (2006.01)
A61K 31/58 (2013.01)
A61P 11/06 (2006.01)
A61P 11/00 (2018.01)
A61P 11/00 (2006.01)
A61P 11/06 (2018.01)
A61K 9/00 (2006.01)
A61P 43/00 (2018.01)
A61K 9/0075 (2013.01)
European patent
(11) Number of the document 3650019
(13) Kind of document T
(96) European patent application number 19214674.4
Date of filing the European patent application 2015-05-27
(97) Date of publication of the European application 2020-05-13
(45) Date of publication and mention of the grant of the patent 2023-09-06
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
201462003764 P 2014-05-28 US
201462004304 P 2014-05-29 US
201462042506 P 2014-08-27 US
Inventors
(72)
BARNES, Neil Christopher , GB
PASCOE, Steven John , US
Grantee
(73) GlaxoSmithKline Intellectual Property Development Limited , GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Title
(54) FLUTICASONE FUROATE IN THE TREATMENT OF COPD
  FLUTICASONE FUROATE IN THE TREATMENT OF COPD